{
  "url": "https://openlegislation.uk/human-medicines-regulations-2012/schedule-34/paragraph-70",
  "json_url": "https://openlegislation.uk/human-medicines-regulations-2012/schedule-34/paragraph-70.json",
  "legislation": "uksi/2012/1916",
  "legislation_title": "The Human Medicines Regulations 2012",
  "legislation_url": "https://openlegislation.uk/human-medicines-regulations-2012",
  "path": "schedule/34/paragraph/70",
  "kind": "paragraph",
  "number": "70",
  "heading": null,
  "text": "In regulation 1(2) of the Medical Devices (Consultation Requirements) (Fees) Regulations 1995 —\n(a) in the definition “authorised medicinal product”—\n(i) in sub-paragraph (b) before “under” insert “ the Human Medicines Regulations 2012 or ”, and\n(ii) in sub-paragraph (c) for “those” substitute “ the latter ”; and\n(b) in the definition “product licence of right” for “section 25(4) of that Act” substitute “ paragraph 3(2) of Schedule 32 to the Human Medicines Regulations 2012 ”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "M",
      "label": "M1",
      "text": "S.I. 1995/449"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2012/1916/schedule/34/paragraph/70",
    "retrieved_at": "2026-10-29T01:24:34.993203+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}